ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.95466
0.07%
Brent Oil
83.855
0.38%
Bitcoin
58,229.35
-0.01%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Poseida Therapeutics Inc (PSTX)

  7. Poseida Therapeutics Inc (PSTX) Noticias

PSTX Poseida Therapeutics Inc

2.85
0.08 (2.89%)
Pre Mercado
Última actualización: 05:49:15
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Poseida Therapeutics Inc PSTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.08 2.89% 2.85 05:49:15
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.77
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202420:30PRNUSAstellas and Poseida Therapeutics Enter Into Research..
01/5/202414:25APSBiotech Soars on Research Collaboration And License..
01/5/202408:00PRNUSAstellas and Poseida Therapeutics Enter Into Research..
18/4/202407:00PRNUSPoseida Therapeutics Announces Strong Lineup of..
17/4/202408:00PRNUSPoseida Therapeutics Hosts Gene Therapy R&D Day Highlighting..
08/4/202411:00PRNUSPoseida Therapeutics Presents New Phase 1 Data at AACR 2024..
01/4/202415:05PRNUSPoseida Therapeutics Announces Inducement Grant Under Nasdaq..
25/3/202415:05PRNUSPoseida Therapeutics Appoints Syed Rizvi, M.D., as Chief..
19/3/202415:05PRNUSPoseida Therapeutics to Present at H.C. Wainwright 2nd..
13/3/202415:05PRNUSPoseida Therapeutics Announces FDA Orphan Drug Designation..
07/3/202415:07PRNUSPoseida Therapeutics Provides Updates and Financial Results..
07/3/202415:05EDGAR2Form 8-K - Current report
04/3/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:05PRNUSPoseida Therapeutics Announces Inducement Grant Under Nasdaq..
08/2/202415:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/1/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:01EDGAR2Form 8-K - Current report
04/1/202407:00PRNUSPoseida Therapeutics Highlights Recent Progress, Strategic..
11/12/202309:31DJNPoseida Therapeutics Shares Climb on Positive Data for Blood..
11/12/202305:06EDGAR2Form 8-K - Current report
10/12/202311:00PRNUSPoseida Therapeutics Presents Positive Early Results from..
09/11/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:05EDGAR2Form 8-K - Current report
09/11/202315:05PRNUSPoseida Therapeutics Provides Updates and Financial Results..
07/11/202307:00PRNUSPoseida Therapeutics to Present at Two Upcoming Investor..
02/11/202308:01PRNUSPoseida Therapeutics to Present at the 65th ASH Annual..
09/10/202315:30PRNUSPoseida Therapeutics Announces Leadership Transition
05/9/202307:00PRNUSPoseida Therapeutics to Present at Two Upcoming Investor..
14/8/202315:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
11/8/202315:48EDGAR2Form D - Notice of Exempt Offering of Securities
08/8/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:06EDGAR2Form 8-K - Current report
08/8/202315:05PRNUSPoseida Therapeutics Provides Financial Results for the..
07/8/202309:41DJNPoseida Therapeutics Shares Leap on Astellas Investments
07/8/202308:58DJNPoseida Therapeutics in $50 Million Investment Deal With..
07/8/202308:01EDGAR2Form 8-K - Current report
07/8/202308:01PRNUSPoseida Therapeutics Announces Strategic Investment by..
07/8/202308:00PRNUSAstellas and Poseida Therapeutics Announce Strategic..
05/7/202307:00PRNUSPoseida Therapeutics Announces FDA Clearance of..
26/6/202307:00PRNUSPoseida Therapeutics to Join Russell 3000® and Russell 2000®..
01/6/202307:00PRNUSPoseida Therapeutics Announces Virtual 2023 Annual Meeting..
23/5/202307:00PRNUSPoseida Therapeutics to Present at Stifel 2023 Tailoring..
22/5/202307:00PRNUSPoseida Therapeutics to Present at 31st Congress of the..
18/5/202307:00PRNUSPoseida Therapeutics Presents Encouraging Preclinical Data..
09/5/202315:05PRNUSPoseida Therapeutics Provides Updates and Financial Results..

Su Consulta Reciente

NASDAQ
PSTX
Poseida Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados